Skip to main content

Table 3 Baseline characteristics of non-PCOS and PCOS without HA participants

From: PCOS without hyperandrogenism is associated with higher plasma Trimethylamine N-oxide levels

 

Control

PCOS-N

P-Value

IFN-α (pg/ml)

3.02 (2.53–4.61)

3.11 (1.94–4.15)

0.763

IFN-γ (pg/ml)

4.16 (3.03–5.70)

4.52 (3.61–5.99)

0.477

TNF-α (pg/ml)

3.34 (2.27–3.44)

3.24 (2.19–3.54)

0.646

MCP-1 (pg/ml)

154.38 (94.27–218.21)

167.53 (130.18–197.62)

0.613

IL-6 (pg/ml)

3.78 (3.66–7.90)

3.93 (3.66–9.23)

0.362

IL-8 (pg/ml)

11.47 (9.01–16.01)

11.03 (9.30–14.41)

0.603

IL-10 (pg/ml)

5.99 (3.72–7.66)

4.69 (3.76–8.07)

0.837

IL-17A (pg/ml)

1.89 (1.08–1.94)

1.92 (1.34–2.29)

0.179

IL-18 (pg/ml)

272.61 (177.57–377.55)

310.25 (209.55–490.93)

0.521

IL-33 (pg/ml)

37.71 (18.84–45.74)

31.60 (12.77–49.29)

0.785

Plasma TMAO (μmol/L)

1.65 (1.01–2.38)

2.37 (1.77–5.78)

0.003*

  1. Data are presented as median (interquartile range). (*) represents significant difference between groups, p < 0.01; (**) represents significant difference between groups, p < 0.0001. IFN-α Interferon alpha, IFN-γ Interferon gamma, TNF-α Tumor necrosis factor alpha, MCP-1 Monocyte chemoattractant protein-1, IL-6 Interleukin 6, IL-8 Interleukin 8, IL-10 Interleukin 10, IL-17A Interleukin 17A, IL-18 Interleukin 18, IL-33 Interleukin 33, TMAO Trimethylamine N-oxide